Isothrive Inc
We treat chronic disease caused by microbiome dysbiosis. Our first indication affects 1/3 US population and presents a $16B annual market opportunity. Beyond that, we have disrupted drug discovery with a shorter timeline to market, faster investment return and relatively small up front investment. With our Lightning Rapid Carbohydrate Drug Discovery Platform, we have a pipeline of novel MIMOs targeting a range of upper and lower GI conditions.
7-day free trial · no credit card
Verified contacts
10
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
3
tools in use
Monthly traffic
43
organic / mo
Sign up free to see all 10 verified contacts at Isothrive Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
10 contacts with verified email or phone · masked until revealed.
- JF
James Farrell
Director · General Business & Management
EmailPhone - AJ
Alyssa Jernigan
Clinical Research Project Manager · Healthcare & Human Services
EmailPhone - EH
Elizabeth Holtom
Clinical Research Coordinator · Healthcare & Human Services
EmailPhone - PS
Peter Swann
Co-founder, Chief Medical Officer · Healthcare & Human Services
EmailPhone - TH
Tina Higginbotham
Vice President of Clinical Research Operations · Other
EmailPhone - LO
Lyn Oswald
COO · General Business & Management
EmailPhone
Showing 6 of 10 verified contacts
Top roles at Isothrive Inc
7 distinct titles indexed · top 7 shown.
- 2clinical research coordinator
- 2coo
- 1clinical research project manager
- 1co-founder, chief medical officer
- 1director
- 1research scientist
- 1vice president of clinical research operations
Sign up to unlock all 10 contacts at Isothrive Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 10 verified contacts at Isothrive Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.